FDA Inspection 1169304 — Stephanie Hastings, PhD
The FDA completed an inspection of Stephanie Hastings, PhD on Apr 28, 2022 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 28, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Durham, NC (United States)
Additional Details
Clinical Investigator (CI)